Elsevier

Respiratory Medicine

Volume 102, Issue 9, September 2008, Pages 1305-1310
Respiratory Medicine

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis

https://doi.org/10.1016/j.rmed.2008.03.022Get rights and content
Under an Elsevier user license
open archive

Summary

Rationale

Pulmonary hypertension (PH) commonly complicates the course of patients with idiopathic pulmonary fibrosis (IPF). It has a significant impact on outcomes and is, therefore, important to detect.

Objectives

We sought to characterize the accuracy and performance characteristics of the right ventricular systolic pressure (RVSP) as estimated by echocardiography (ECHO) alone and in conjunction with physiologic indices in predicting the presence of PH in IPF patients.

Methods

Cross-sectional study of IPF patients from two large tertiary centers in whom both ECHO and right-heart catheterization (RHC) were available.

Measurements and main results

There were 110 patients with available ECHOs and RHCs. Estimates of RVSP were reported in 60 of these patients (54.5%) of whom 22 (36.6%) had PH, while 16 of the 50 patients without RVSP estimate (32%) had PH. Twenty-four of 60 (40%) ECHOs accurately reflected the pulmonary arterial systolic pressure as measured by RHC. An optimal RVSP threshold for the screening of PH could not be detected. When assessed in combination with various thresholds of PFT and 6-minute walk test (6MWT) parameters, the performance characteristics of the RVSP were slightly improved.

Conclusion

The RVSP is not an accurate test for the assessment of PH in IPF patients. Awareness of the various combinations of threshold values for RVSP with and without PFT and 6MWT might nonetheless assist clinicians in risk stratifying IPF patients for the presence of PH.

Keywords

Hypertension
Pulmonary
Oximetry
Pulmonary fibrosis
Pulmonary function tests
Pressure
Pulmonary artery

Abbreviations

DLCO
Diffusing Capacity for Carbon Monoxide
DLCO%
Diffusing Capacity for Carbon Monoxide Percent Predicted
ECHO
Echocardiography
FVC
Forced Vital Capacity
FVC%
Forced Vital Capacity Percent Predicted
IPF
Idiopathic Pulmonary Fibrosis
mPAP
Mean Pulmonary Artery Pressure
PAP
Pulmonary Artery Pressure
PASPcath
Pulmonary Artery Systolic Pressure obtained via right-heart catheterization
PFTs
Pulmonary Function Tests
PH
Pulmonary Hypertension
RHC
Right-Heart Catheterization
RVSPecho
Right Ventricular Systolic Pressure as estimated by echocardiography
6MWT
The six-minute walk test
6MWD
The 6-minute walk test distance
RAsatrest
Oxygen saturation on room air at rest
RAsatexercise
Room air oxygen saturation with exercise

Cited by (0)

Dr. Zisman is funded by the National Institutes of Health IPF Clinical Research Network, which includes participation in a pulmonary hypertension study with sildenafil. This work was supported, in part, by grants from the NIH (5U10HL080411 to DAZ; HL080206 and HL086491 to JAB).